Finally, to investigate whether CNPY2 inhibited MYLIP-mediated AR degradation in prostate cancer cells, AR protein levels were examined by immunoblotting of lysates from either CNPY2 or MYLIP knockdown LNCaP cells (Figure 2H). Here, AR is linked to prostate cancer.